Literature DB >> 18514180

Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice.

Michael Dellinger1, Robert Hunter, Michael Bernas, Nicholas Gale, George Yancopoulos, Robert Erickson, Marlys Witte.   

Abstract

Molecular mechanisms regulating the remodeling of the lymphatic vasculature from an immature plexus of vessels to a hierarchal network of initial and collecting lymphatics are not well understood. One gene thought to be important for this process is Angiopoietin-2 (Ang-2). Ang2(-/-) mice have previously been reported to exhibit an abnormal lymphatic phenotype but the precise nature of the lymphatic defects and the underlying mechanisms have yet to be defined. Here we demonstrate by whole-mount immunofluorescence staining of ear skin and mesentery that lymphatic vessels in Ang2(-/-) mice fail to mature and do not exhibit a collecting vessel phenotype. Furthermore, dermal lymphatic vessels in Ang2(-/-) pups prematurely recruit smooth muscle cells and do not undergo proper postnatal remodeling. In contrast, Ang2 knock-out Ang1 knock-in mice do develop a hierarchal lymphatic vasculature, suggesting that activation of Tie-2 is required for normal lymphatic development. Taken together, this work pinpoints a specific lymphatic defect of Ang2(-/-) mice and further defines the sequential steps in lymphatic vessel remodeling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18514180      PMCID: PMC2536689          DOI: 10.1016/j.ydbio.2008.04.024

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  40 in total

1.  Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.

Authors:  Nicholas W Gale; Gavin Thurston; Sean F Hackett; Roumiana Renard; Quan Wang; Joyce McClain; Cliff Martin; Charles Witte; Marlys H Witte; David Jackson; Chitra Suri; Peter A Campochiaro; Stanley J Wiegand; George D Yancopoulos
Journal:  Dev Cell       Date:  2002-09       Impact factor: 12.270

Review 2.  Regulation of lymphangiogenesis--from cell fate determination to vessel remodeling.

Authors:  Terhi Karpanen; Taija Mäkinen
Journal:  Exp Cell Res       Date:  2005-12-15       Impact factor: 3.905

3.  A fluorescent Tie1 reporter allows monitoring of vascular development and endothelial cell isolation from transgenic mouse embryos.

Authors:  Kristina Iljin; Tatiana V Petrova; Tanja Veikkola; Vijay Kumar; Matti Poutanen; Kari Alitalo
Journal:  FASEB J       Date:  2002-11       Impact factor: 5.191

4.  Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF).

Authors:  Richard P Visconti; Charlene D Richardson; Thomas N Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

5.  Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo.

Authors:  Ivan B Lobov; Peter C Brooks; Richard A Lang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-05       Impact factor: 11.205

6.  Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.

Authors:  Marika J Karkkainen; Paula Haiko; Kirsi Sainio; Juha Partanen; Jussi Taipale; Tatiana V Petrova; Michael Jeltsch; David G Jackson; Marja Talikka; Heikki Rauvala; Christer Betsholtz; Kari Alitalo
Journal:  Nat Immunol       Date:  2003-11-23       Impact factor: 25.606

7.  Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.

Authors:  Lin Zhang; Nuo Yang; Jin-Wan Park; Dionyssios Katsaros; Stefano Fracchioli; Gaoyuan Cao; Ann O'Brien-Jenkins; Thomas C Randall; Stephen C Rubin; George Coukos
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

8.  Angiopoietin-2 plays an important role in retinal angiogenesis.

Authors:  Sean F Hackett; Stanley Wiegand; George Yancopoulos; Peter A Campochiaro
Journal:  J Cell Physiol       Date:  2002-08       Impact factor: 6.384

9.  Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy.

Authors:  Hans-Peter Hammes; Jihong Lin; Patrick Wagner; Yuxi Feng; Franziska Vom Hagen; Thomas Krzizok; Oliver Renner; Georg Breier; Michael Brownlee; Urban Deutsch
Journal:  Diabetes       Date:  2004-04       Impact factor: 9.461

10.  Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis.

Authors:  M Hellström; H Gerhardt; M Kalén; X Li; U Eriksson; H Wolburg; C Betsholtz
Journal:  J Cell Biol       Date:  2001-04-30       Impact factor: 10.539

View more
  86 in total

1.  Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax.

Authors:  John D Kanady; Michael T Dellinger; Stephanie J Munger; Marlys H Witte; Alexander M Simon
Journal:  Dev Biol       Date:  2011-04-16       Impact factor: 3.582

2.  Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature.

Authors:  Jan Kazenwadel; Genevieve A Secker; Yajuan J Liu; Jill A Rosenfeld; Robert S Wildin; Jennifer Cuellar-Rodriguez; Amy P Hsu; Sarah Dyack; Conrad V Fernandez; Chan-Eng Chong; Milena Babic; Peter G Bardy; Akiko Shimamura; Michael Y Zhang; Tom Walsh; Steven M Holland; Dennis D Hickstein; Marshall S Horwitz; Christopher N Hahn; Hamish S Scott; Natasha L Harvey
Journal:  Blood       Date:  2011-12-06       Impact factor: 22.113

3.  Macrophages define dermal lymphatic vessel calibre during development by regulating lymphatic endothelial cell proliferation.

Authors:  Emma J Gordon; Sujata Rao; Jeffrey W Pollard; Stephen L Nutt; Richard A Lang; Natasha L Harvey
Journal:  Development       Date:  2010-11       Impact factor: 6.868

4.  A New Conserved Player in Lymphatic Morphogenesis.

Authors:  Nathan D Lawson
Journal:  Circ Res       Date:  2017-04-14       Impact factor: 17.367

Review 5.  Molecular regulation of tumor angiogenesis and perfusion via redox signaling.

Authors:  Thomas W Miller; Jeff S Isenberg; David D Roberts
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

Review 6.  Receptor tyrosine kinase-mediated angiogenesis.

Authors:  Michael Jeltsch; Veli-Matti Leppänen; Pipsa Saharinen; Kari Alitalo
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

7.  An immunological fingerprint differentiates muscular lymphatics from arteries and veins.

Authors:  Eric A Bridenbaugh; Wei Wang; Maya Srimushnam; Walter E Cromer; Scott D Zawieja; Susan E Schmidt; Daniel C Jupiter; Hung-Chung Huang; Vincent Van Buren; David C Zawieja
Journal:  Lymphat Res Biol       Date:  2013-09       Impact factor: 2.589

8.  Altered lymphatics in an ovine model of congenital heart disease with increased pulmonary blood flow.

Authors:  Sanjeev A Datar; Eric G Johnson; Peter E Oishi; Michael Johengen; Eric Tang; Angela Aramburo; Jubilee Barton; Hsuan-Chang Kuo; Stephen Bennett; Konstantine Xoinis; Bhupinder Reel; Gokhan Kalkan; Eniko Sajti; Oscar Osorio; Gary W Raff; Michael A Matthay; Jeffrey R Fineman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-29       Impact factor: 5.464

9.  Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors.

Authors:  David M Hyman; Naiyer Rizvi; Ronald Natale; Deborah K Armstrong; Michael Birrer; Lawrence Recht; Efrat Dotan; Vicky Makker; Thomas Kaley; Denison Kuruvilla; Matthew Gribbin; Jennifer McDevitt; Dominic W Lai; Mohammed Dar
Journal:  Clin Cancer Res       Date:  2018-03-20       Impact factor: 12.531

10.  Angiopoietin-2 in experimental colitis.

Authors:  Vijay C Ganta; Walter Cromer; Ginny L Mills; James Traylor; Merilyn Jennings; Sarah Daley; Benjamin Clark; J Michael Mathis; Michael Bernas; Moheb Boktor; Paul Jordan; Marlys Witte; J Steven Alexander
Journal:  Inflamm Bowel Dis       Date:  2010-06       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.